Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Fezakinumab> ?p ?o. }
Showing items 1 to 34 of
34
with 100 items per page.
- Fezakinumab abstract "Fezakinumab is a human monoclonal antibody against interleukin-22, designed for the treatment of psoriasis and rheumatoid arthritis.Wyeth discovered and initially developed the drug, and clinical development continued after that company was acquired by Pfizer. Fezakinumab, in combination with methotrexate, completed a phase II trial in rheumatoid arthritis, but data was not released. Development was discontinued in August 2011.".
- Fezakinumab atcPrefix "none".
- Fezakinumab casNumber "1007106-86-6".
- Fezakinumab fdaUniiCode "0S77U25XZ3".
- Fezakinumab wikiPageID "33024211".
- Fezakinumab wikiPageRevisionID "514521053".
- Fezakinumab atcPrefix "none".
- Fezakinumab c "6408".
- Fezakinumab casNumber "1007106".
- Fezakinumab chemspiderid "NA".
- Fezakinumab h "9873".
- Fezakinumab hasPhotoCollection Fezakinumab.
- Fezakinumab mabType "mab".
- Fezakinumab molecularWeight "143.87".
- Fezakinumab n "1706".
- Fezakinumab o "2016".
- Fezakinumab s "44".
- Fezakinumab source "u".
- Fezakinumab target Interleukin_13.
- Fezakinumab type "mab".
- Fezakinumab unii "0".
- Fezakinumab verifiedfields "changed".
- Fezakinumab verifiedrevid "457119778".
- Fezakinumab subject Category:Wyeth.
- Fezakinumab type Drug.
- Fezakinumab type FunctionalSubstance.
- Fezakinumab comment "Fezakinumab is a human monoclonal antibody against interleukin-22, designed for the treatment of psoriasis and rheumatoid arthritis.Wyeth discovered and initially developed the drug, and clinical development continued after that company was acquired by Pfizer. Fezakinumab, in combination with methotrexate, completed a phase II trial in rheumatoid arthritis, but data was not released. Development was discontinued in August 2011.".
- Fezakinumab label "Fezakinumab".
- Fezakinumab label "فيزاكينوماب".
- Fezakinumab sameAs m.0h53gkx.
- Fezakinumab sameAs Q5446179.
- Fezakinumab sameAs Q5446179.
- Fezakinumab wasDerivedFrom Fezakinumab?oldid=514521053.
- Fezakinumab isPrimaryTopicOf Fezakinumab.